{"artifact_id":"hypothesis-h-23a3cc07","artifact_type":"hypothesis","title":"Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation","quality_score":0.532,"is_latest":1,"version_number":4,"version_count":1,"debate_count":2,"supports_count":0,"contradicts_count":0,"neutral_count":2,"incoming_by_type":{"derives_from":8,"related":1280,"supports":32,"partial_answer_for":1,"discriminating_experiment":1,"experiment_target":7,"mentions":2094},"total_incoming":3423,"outgoing_by_type":{"targets":1,"derives_from":1,"related":2048,"supports":26,"see_also":4,"mentions":6},"total_outgoing":2086,"quality_trajectory":[{"score":0.532,"at":"2026-05-16T14:51:34.657673-07:00"},{"score":0.532,"at":"2026-05-16T08:03:22.955306-07:00"},{"score":0.532,"at":"2026-04-28T03:48:49.857966-07:00"}],"evidence_balance":0.0,"evidence_certainty":1.0,"total_evidence_items":5511,"is_well_supported":false,"is_controversial":false,"is_foundational":true}